337904-77-5

Basic information

• Product Name: 2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI)
• Synonyms: 2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI);6-Isopropylpyridine-2-car...;6-Isopropylpyridine-2-carboxylic acid;6-(propan-2-yl)pyridine-2-carboxylic acid;6-Isopropylpicolinic acid
• CAS NO: 337904-77-5
• Molecular Formula: C₉H₁₁NO₂
• Molecular Weight: 165.19
• Product Categories: GLYCINESCAFFOLD;ISOPROPYL
• Mol File: 337904-77-5.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI)(337904-77-5)
• EPA Substance Registry System: 2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI)(337904-77-5)

Safety Data

• Hazardous Substances Data: 337904-77-5(Hazardous Substances Data)

Usage

General Description

2-Pyridinecarboxylicacid,6-(1-methylethyl)-(9CI) is a chemical compound more commonly referred to as Isonicotinic Acid, Isopropyl Ester. It is typically used in the field of organic synthesis. This chemical has a molecular formula of C9H11NO2 and a molecular weight of 165.19 g/mol. Available as a clear, colorless to pale yellow liquid, it has a slight odor and is stable under normal temperatures and pressures. Isonicotinic Acid, Isopropyl Ester is not classified as hazardous but should be handled with care as it may cause irritation to the skin, eyes, and respiratory tract.

Upstream product

• 337904-76-4 6-isopropylpyridine-2-carbonitrile 

Downstream Products

• 923604-99-3 6-isopropylpyridine-2-carboxylic acid (6-acetyl-3-methoxy-2-methylphenyl)amide 
• 1310551-61-1 6-Isopropyl-pyridine-2-carboxylic acid [6-acetyl-2-chloro-3-(2-methoxy-ethoxy)-phenyl]-amide 

Relevant articles and documents

MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS

Inhibitors of HCV replication of formula (I) and the N-oxides, salts, and stereoisomers, wherein each dashed line represents an optional double bond; X is N, CH and where X bears a double bond it is C; R1 is -OR7, -NH-SO2R8; R2 is hydrogen, and where X is C or CH, R2 may also be C1-6alkyl; R3 is hydrogen, C1-6alkyl, C1-6alkoxyC1-6alkyl, C3-7cycloalkyl; R4 is aryl or Het; n is 3, 4, 5, or 6; R5 is halo, C1-6alkyl, hydroxy, C1-6alkoxy, phenyl, or Het; R6 is C1-6alkoxy, or dimethylamino; R7 is hydrogen; aryl; Het; C3-7cycloalkyl optionally substituted with C1-6alkyl; or C1-6alkyl optionally substituted with C3-7cycloalkyl, aryl or with Het; R8 is aryl; Het; C3-7cycloalkyl optionally substituted with C1-6alkyl; or C1-6alkyl optionally substituted with C3-7cycloalkyl, aryl or with Het; aryl is phenyl optionally substituted with one, two or three substituents; Het is a 5 or 6 membered saturated, partially unsaturated or completely unsaturated heterocyclic ring containing 1 to 4 heteroatoms selected from nitrogen, oxygen and sulfur, and being optionally substituted with one, two or three substituents ; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.